Project Grant R21NS142826

Award Date 5/15/25
Completion Date 4/30/27
Dollars Obligated $432K
Federal Grant Program
93.853
Assistance Type
Project Grant
Place of Performance
East Lansing, MI 48824, USA
Similar Awards
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $606,548.00 to the University of Pittsburgh to develop a new brain recording technology called "mesoscopic electrophysiology." This innovative system will use a 3D grid of 1,920 intracranial electrodes to simultaneously record neural activity across an entire...
The Regents of the University of Michigan was awarded a $646,000 project grant from the National Institute of Neurological Disorders and Stroke (NINDS), under the 21st Century Cures Act - Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative (CFDA 93.372). The funding will support research to identify the neural processes within the paraventricular nucleus of the thalamus (PVT) that underlie individual variation in cue-motivated behavior. Using fluorescence-based...
This Project Grant award from the National Institutes of Health (NIH) Office of the Director, under the Trans-NIH Research Support program (CFDA 93.310), provides $2,156,000 to the Regents of the University of Minnesota to develop and validate novel neuroimaging methods for studying cerebral blood flow, oxygen availability, pH, and carbon dioxide levels in the brain. The goal is to establish a transformative approach for non-invasively quantifying these critical metabolic parameters, which are...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $419,038 Project Grant (CFDA 93.853 - Extramural Research Programs in the Neurosciences and Neurological Disorders) to the University of North Dakota to develop a miniature selective plane illumination fluorescence microscope for high-resolution volumetric imaging in freely behaving mice. The goal is to create a transformative machine learning-augmented miniature adaptive optics light-sheet microscopy platform to...
This Project Grant awarded by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program provides $244,500.00 to Yale University to develop a new computational technology for processing PET/SPECT neuroimages. The research aims to enable reference-region-free analysis of PET/SPECT images, thereby expanding the use of radiotracers that lack an optimal reference...
This $497,196 Project Grant awarded by the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program, supports the development of a novel magnetic resonance spectroscopic imaging (MRSI) pulse sequence. The objective is to simultaneously map both upfield (UF) and downfield (DF) proton signals throughout the human brain at 3T, which may provide valuable metabolic...
The National Institute of Mental Health (NIMH) awarded a $1,596,935 Project Grant under the Mental Health Research Grants program (CFDA 93.242) to Petcoil, Inc., a for-profit medical technology company in Sunnyvale, California. The grant supports the development and commercialization of a portable, brain-dedicated Positron Emission Tomography (PET) insert system that can be integrated with existing Magnetic Resonance Imaging (MRI) scanners. This innovative solution aims to significantly reduce...
The National Institutes of Health's National Institute of Neurological Disorders and Stroke awarded a $3,045,502 Project Grant to the Regents of the University of Michigan on August 18, 2022 under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). The grant funds the development of optical neural motes to enable high-density neural recording through intact dura in nonhuman primates. Specifically, the University of Michigan will design...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program, aims to develop a portable, battery-powered backpack sampling platform that can integrate with commercial microdialysis probes and 3D printed microsampling probes. The $147,519 award, granted on January 8, 2025, will enable the creation of a prototype backpack system that...
The University of Michigan was awarded a $1,345,424 Project Grant from the National Institutes of Health's Trans-NIH Research Support program (CFDA 93.310) to develop a genetically encoded "protein ticker tape" recording system. This innovative technology aims to enable long-term, brain-wide recording of single-cell physiology and gene expression in live mice, without the need for external interfaces. The 3-year project will leverage expertise in protein engineering and neurotechnology...

This $431,750 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program, supports the development of an innovative Positron Emission Tomography (PET) molecular neuroimaging technique. The goal is to non-invasively and repeatedly image whole-brain neurocircuitry involved in complex behaviors and cognitive tasks in awake mammals. The approach leverages a brain-penetrant PET imaging probe and a neuronal activity-dependent reporter protein to map activated neurons and elucidate the underlying neural circuits. Successful demonstration in mice is expected to enable translation of this paradigm to larger animal models like pigs, which could provide valuable insights into the adaptations of neural circuitry in more complex brains and behaviors. This 2-year project, with a performance period from May 2025 to April 2027, is a collaborative effort between Henry Ford Health and Michigan State University Health Sciences.

Generated 6/17/25, 5:28 AM